Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
D000917:Antibody Formation; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005334:Fever / Q000209:etiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007223:Infant; D008297:Male; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine; D009107:Mumps / Q000517:prevention & control*; D009108:Mumps Vaccine; D009500:Neutralization Tests; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000009:adverse effects
D008458:Measles Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D014765:Viral Vaccines